Ophthotech's Series B Round

Ophthotech raised a round of funding on December 24, 2009.

Ophthotech is a biopharmaceutical company focusing on discovering, developing and commercializing first-in-class therapies for the treatment of major ophthalmic diseases. Ophthotech's lead compound Fo…

Articles about Ophthotech's Series B Round: